TrialBritish journal of cancer2026

Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study.

Benoit Blanchet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.